Kivorent News

Wednesday, November 18, 2026

Health techNews

Inovalon agrees to buy e-prescribing company DrFirst

Inovalon, the Nordic Capital-backed health data company, signed a deal on November 11 to acquire DrFirst, adding prescribing, prior authorization and benefit tools used across more than 270 electronic health records.

Docket, covering health regulation and AI in care
, 3 min read

241M+Prescriptions a year written through DrFirst's network

What to know

  • Inovalon signed a definitive agreement on November 11 to acquire DrFirst; financial terms were not disclosed.
  • Inovalon says DrFirst reaches more than 2,000 hospitals and 240,000 prescribing providers who write over 241 million prescriptions a year across more than 270 EHR integrations.
  • The deal still needs regulatory approvals and other customary closing conditions, and no closing date was given.

Inovalon, a health care data and software company backed by the private equity firm Nordic Capital, has signed a definitive agreement to acquire DrFirst, a company whose software sits inside doctors' electronic health records (EHRs) at the moment they write a prescription. The companies announced the deal on November 11 from Bowie, Maryland, and Arlington, Virginia. Financial terms were not disclosed, according to the release and HCI Innovation Group.

What DrFirst does

DrFirst has spent more than 25 years building electronic prescribing (e-prescribing) tools. Inovalon's release describes its products as prescribing, prior authorization, benefit determination and patient communications software. In practice, that means checking what a drug will cost a patient under their plan, starting the insurer's approval process when one is needed, and sending the prescription to the pharmacy, all from inside the clinician's record system.

According to Inovalon, DrFirst's tools reach more than 2,000 hospitals and 240,000 prescribing providers, who write over 241 million prescriptions a year through more than 270 EHR integrations. DrFirst's own boilerplate in the same release gives a broader figure of more than 670,000 providers and 71,000 pharmacies; the release does not explain the difference, and this story uses the 240,000 prescriber figure that both Inovalon and HCI Innovation Group report for the deal.

What Inovalon gets

Inovalon sells analytics and software to health plans, providers and drugmakers. It says its platform draws on more than 99 billion medical, pharmacy and lab events covering 461 million unique patients, and that it has more than 50,000 active licensed customers. The release says DrFirst will add real-time prescription drug and prior authorization capabilities to that data.

Inovalon chief executive Adam Kansler said DrFirst's "clinical-grade AI will further extend our reach to the point of care." DrFirst chief executive Laizer Kornwasser framed the deal as a way to coordinate more closely across the steps between a prescription and a patient starting therapy. Neither company said what roles its executives will hold after the deal closes.

HIT Consultant, in its own analysis, expects the combined company to put formulary alternatives, out-of-pocket cost estimates and automated prior authorization in front of prescribers. Those are the trade publication's expectations, not commitments in the announcement.

Deal details

The acquisition is subject to required regulatory approvals and other customary closing conditions, and the companies gave no expected closing date. Citigroup is DrFirst's financial adviser and Skadden is its legal adviser. Goldman Sachs advised Inovalon and Nordic Capital, with Kirkland & Ellis as legal counsel and McDermott Will & Schulte advising Inovalon on regulatory, privacy and health care matters.

The deal lands in a busy week for digital health dealmaking, two days after Oura agreed to buy AI primary care startup Counsel Health.

Why it matters

Prescribing is where cost and insurance approval problems most often delay treatment, and the deal puts an e-prescribing network used by hundreds of thousands of prescribers under a company whose business is selling data and analytics to health plans and providers. If it closes, one owner would hold both the health plan data and the screen where doctors write prescriptions, which the companies say will speed up benefit checks and prior authorization. The timing also overlaps with federal rule changes on how prescriptions move, from telehealth prescribing of controlled substances to Medicare's payment rules for remote monitoring and digital care.

This article is general information about how technology works. It is not medical advice. Talk to a clinician about your own health.

Sources

Digital health and AI in care

Written by an AI correspondent under standards set by editor Jacob Knight. Spotted an error? Tell us and we will fix it.